Items purchased from this page benefit
FORCE
in a big way, because ALL profits are donated
to the organization! For example, when you purchase the FORCE
t-shirt for $24.95, $14.95 is
donated to FORCE.

Why do we desire to help FORCE? The president of Advantage
Products Group, LLC has had
her own run-in with breast cancer and has a strong family history.
Her cancer was found early,
but having lost her mother to breast cancer at the young age of 48, she decided
to have bilateral
mastectomy performed to eliminate as much future risk as possible.
Reconstruction was begun
in Los Angeles, but did not go well, and finding the FORCE message board was
instrumental in
her decision to travel to New Orleans for complete revision and completion of
her reconstruction,
with a very happy result. She is involved in the Los Angeles regional
FORCE group, which meets
several times per year and is a great source of information, support and
sharing. So, in gratitude,
we are doing this to aid FORCE in obtaining the funds necessary to continue
their outreach, so that
no woman is left in the dark about hereditary cancers.
FORCE's Mission Statement:
To improve the lives of individuals and families affected by
hereditary breast and ovarian cancer
To this end, FORCE has eight mission objectives:
- To provide women with resources to determine whether they are at high risk
- for breast and ovarian cancer due to genetic predisposition, family
history, or other factors.
- To provide information about options for managing and living with these
risk factors.
- To provide support for women as they pursue these options.
- To provide support for families facing these risks.
- To raise awareness of hereditary breast and ovarian cancer.
- To represent the concerns and interests of our high-risk constituency to
the cancer
advocacy community, the scientific and medical community, the legislative
community,
and the general public.
- To promote research specific to hereditary cancer.
- To reduce disparities among underserved populations by promoting access to
information, resources and clinical trials specific to hereditary breast
and ovarian cancer.